An FDA-approved drug structurally and phenotypically corrects the K210del mutation in genetic cardiomyopathy models.
FDA 批准的一种药物在结构和表型上纠正了遗传性心肌病模型中的 K210del 突变
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI174081
Wang Ping, Ahmed Mahmoud Salama, Nguyen Ngoc Uyen Nhi, Menendez-Montes Ivan, Hsu Ching-Cheng, Farag Ayman B, Thet Suwannee, Lam Nicholas T, Wansapura Janaka P, Crossley Eric, Ma Ning, Zhao Shane Rui, Zhang Tiejun, Morimoto Sachio, Singh Rohit, Elhelaly Waleed, Tassin Tara C, Cardoso Alisson C, Williams Noelle S, Pointer Hayley L, Elliott David A, McNamara James W, Watt Kevin I, Porrello Enzo R, Sadayappan Sakthivel, Sadek Hesham A
